These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6157867)

  • 21. [Analysis of the electrophoretic mobility of lipoprotein fractions].
    Kurilovich SA; Filimonova TA; Vereshchagina GN
    Lab Delo; 1982; (9):534-6. PubMed ID: 6183517
    [No Abstract]   [Full Text] [Related]  

  • 22. Determinants of thyroid hormone and thyroid-lipid interrelationships in Jerusalem.
    Slater PE; Kark JD; Friedlander Y; Kaufmann NA
    Isr J Med Sci; 1984 Dec; 20(12):1158-63. PubMed ID: 6519947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Age-related characteristics of the normal blood content of lipids and lipoproteins and in arterial hypertension].
    Tokar AV; Chaialo PP; Rudaia ES; Shevchenko VA
    Vutr Boles; 1983; 22(5):71-6. PubMed ID: 6673337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum sex hormones in premenopausal women with coronary heart disease.
    Mohamad MJ; Karayyem M; Mohammad MA; Al-Alami J; Al-Hader A
    Neuro Endocrinol Lett; 2006 Dec; 27(6):758-62. PubMed ID: 17186999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cyclic adenosine monophosphate concentration in the blood plasma in coronary arteriosclerosis and its relationship to the nature of the metabolic disorders].
    Bobkova VI; Sidakova NM; Iurkiv VA; Oparina EI; Sukasova TI
    Kardiologiia; 1980 Mar; 20(3):87-91. PubMed ID: 6246304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease.
    Morishita E; Hashimoto T; Asakura H; Saito M; Yamazaki M; Aoshima K; Yoshida T; Kato H; Matsuda T
    Thromb Haemost; 1998 May; 79(5):919-23. PubMed ID: 9609221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperlipoproteinemia in patients hospitalized for ischemic coronary disease and myocardial infarct].
    Cisarik F; Gavalec M; Zánová J; Hrbánová Z
    Vnitr Lek; 1981 Feb; 27(2):137-41. PubMed ID: 7467156
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in the surface charge of lipoproteins isolated from the plasma of persons with hyperalphalipoproteinemia].
    Formaziuk VE; Dobretsov GE; Vladimirov IuA
    Vopr Med Khim; 1981; 27(1):125-9. PubMed ID: 7467200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
    de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
    Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lipoprotein (a) in coronary heart disease and myocardial infarction].
    Wottawa A; Fromme K; Klein G
    MMW Munch Med Wochenschr; 1984 Jan; 126(3):53-5. PubMed ID: 6230531
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fatty acid makeup of different lipid fractions of plasma lipoproteins in persons dying suddenly from coronary heart disease].
    Aptekar' SG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):36-42. PubMed ID: 7259866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V; Klör HU; Wechsler JG; Ditschuneit H
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Familial normolipidemic dyslipoproteinemia].
    Bicanová J; Kelbich J; Scheihauer E
    Vnitr Lek; 1981 Feb; 27(2):115-21. PubMed ID: 7467153
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma lipids and lipoprotein cholesterol in patients with premature ischaemic heart disease and ischaemic cerebrovascular disease.
    Das S; Tripathy BB; Bidyadhar S; Das JP; Rath S; Swain AK; Das DK
    J Assoc Physicians India; 1984 Nov; 32(11):949-54. PubMed ID: 6526783
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD.
    Bathen TF; Engan T; Krane J; Axelson D
    Anticancer Res; 2000; 20(4):2393-408. PubMed ID: 10953302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-lipoprotein reaction with blood serum in cardiovascular diseases].
    Golod IS
    Sov Med; 1972 Jun; 35(6):22-5. PubMed ID: 4585122
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure.
    Bower S
    J Pharm Pharmacol; 1982 Feb; 34(2):102-6. PubMed ID: 6121867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.
    Vessby B; Lithell H; Boberg J
    Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma lipoprotein alterations in thyroid dysfunction. Roles of lipoprotein lipase, hepatic lipase and LCAT.
    Valdemarsson S
    Acta Endocrinol Suppl (Copenh); 1983; 255():1-52. PubMed ID: 6575562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.